Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report

RATIONALE: Pyrotinib is a novel dual pan-ErbB receptor tyrosine kinase inhibitor, approved for the treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC). However, there was still limited information regarding specific effect of pyrotinib on HER2-positiv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Dai, Jiali, Chen, Yuetong, Tang, Cuiju, Wei, Xiaowei, Gong, Yang, Wei, Jingsun, Gu, Dongying, Chen, Jinfei
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2020
Fag:
5750
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310977/
https://ncbi.nlm.nih.gov/pubmed/32569228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020809
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker